A Study to Evaluate CSJ148 in Pregnant Women With Primary HCMV Infection

Summary

The purpose of the study is to evaluate the feasibility of using CSJ148 to prevent congenital human cytomegalovirus (HCMV) in pregnant women with primary HCMV infection.

Timeline

Start

2018-10-23

Primary completion

2022-11-15

Completion

2022-11-15

Outcome

Outcome not reported

Stopped: “Company decision to withdraw before study started”

Drugs

Indications